Elevated Liver Function (Elevated LFTs), also known as Abnormal Liver Function Tests or Liver Enzyme Elevation, can indicate various underlying health issues. This page provides information on clinical documentation, medical coding, and healthcare best practices related to diagnosing and managing elevated liver enzymes. Learn about the causes, symptoms, and treatment options for patients presenting with abnormal liver function test results. Find resources for accurate medical coding and compliant clinical documentation of Elevated Liver Function for improved patient care and healthcare operations.
Also known as
Abnormal liver function studies
Indicates abnormal results from liver function tests.
Diseases of liver
Covers various liver diseases that can cause elevated LFTs.
Unspecified jaundice
Jaundice can be a sign of underlying liver dysfunction.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is there a documented cause for the elevated liver function?
When to use each related code
| Description |
|---|
| Elevated liver enzymes, suggesting liver dysfunction. |
| Liver inflammation from various causes, including viral infection. |
| Build-up of fat in liver, potentially leading to inflammation and damage. |
Coding elevated liver function without specific test results (e.g., ALT, AST, ALP) lacks detail for accurate reimbursement and may trigger audits.
Failing to document the cause of liver enzyme elevation (e.g., alcohol, medication, hepatitis) impacts severity and can lead to coding errors and denials.
Coding elevated LFTs based on a single, unconfirmed reading without follow-up or supporting documentation risks inaccurate coding and compliance issues.
Q: What is the most effective differential diagnosis approach for persistently elevated liver enzymes in asymptomatic patients?
A: Persistently elevated liver enzymes in asymptomatic patients require a systematic approach to differential diagnosis. Start by repeating the liver function tests (LFTs) to confirm the initial findings and exclude pre-analytical errors. A thorough medical history, including alcohol consumption, medication use (including over-the-counter drugs and herbal supplements), and family history of liver disease, is crucial. Consider implementing serological tests for viral hepatitis (A, B, C), autoimmune hepatitis (e.g., ANA, SMA, LKM-1), and metabolic conditions (e.g., hemochromatosis, Wilson's disease). Non-alcoholic fatty liver disease (NAFLD) is increasingly prevalent and should be suspected, especially with associated metabolic risk factors. Imaging studies, such as ultrasound or transient elastography, can help assess for structural abnormalities and steatosis. If initial investigations are inconclusive, consider referral to a hepatologist for further evaluation, including liver biopsy if indicated. Explore how advanced imaging techniques like MRI with elastography can contribute to a more comprehensive assessment. Ultimately, the differential diagnosis process requires careful consideration of the patient's individual clinical picture and risk factors to determine the most appropriate course of action.
Q: How can I differentiate between alcoholic and non-alcoholic fatty liver disease (NAFLD) based on liver function tests (LFTs) and patient history?
A: While liver function tests (LFTs) can indicate liver injury, they cannot definitively differentiate between alcoholic liver disease (ALD) and NAFLD. Both conditions often present with elevated AST and ALT, with AST typically being higher than ALT in ALD (AST/ALT ratio >2 often, though not always, suggests ALD). However, this ratio is not always reliable. A detailed patient history focusing on alcohol consumption is crucial. Be sensitive yet direct in inquiring about the quantity and frequency of alcohol intake. Inquire about potential hidden sources like cough syrups or mouthwashes containing alcohol. Consider implementing validated questionnaires like the AUDIT-C for screening. Physical examination findings, such as signs of chronic liver disease (e.g., spider angiomata, palmar erythema, splenomegaly), may be more prominent in advanced ALD. Imaging studies (ultrasound, CT, MRI) can help assess liver morphology and fat content. Ultimately, distinguishing between ALD and NAFLD requires a combination of LFTs, thorough history taking, physical examination, and imaging. Learn more about the role of genetic testing in risk stratification and management of NAFLD.
Patient presents with elevated liver function tests (LFTs), indicating abnormal liver function. Presenting complaints may include fatigue, jaundice, abdominal pain or discomfort, nausea, dark urine, or pale stools. Physical examination findings could reveal hepatomegaly, splenomegaly, or right upper quadrant tenderness. Differential diagnoses include viral hepatitis, non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), drug-induced liver injury (DILI), autoimmune hepatitis, biliary obstruction, and metabolic disorders. Laboratory tests ordered include a comprehensive metabolic panel (CMP), complete blood count (CBC), hepatitis panel, and liver imaging such as ultrasound or MRI. Diagnosis of elevated LFTs is based on abnormal levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and bilirubin. Treatment plan depends on the underlying cause and may include lifestyle modifications such as weight loss and dietary changes, medications to manage underlying conditions, or referral to a gastroenterologist or hepatologist for further evaluation and management. Patient education focuses on the importance of adherence to the treatment plan, regular monitoring of liver function, and avoidance of hepatotoxic substances. ICD-10 codes for elevated liver enzymes include R74.8 and the specific code for the underlying cause. CPT codes for related services may include evaluation and management codes, laboratory test codes, and imaging procedure codes. Follow-up appointments are scheduled to monitor LFT levels and assess treatment response.